- Home
- QDEL vs OMCL Comparison
QDEL vs OMCL Comparison
Compare QDEL & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QDEL | OMCL |
|---|---|---|
| Founded | 1979 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2022 | 2000 |
Fundamental Metrics
Financial Performance| Metric | QDEL | OMCL |
|---|---|---|
| Price | $21.38 | $41.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $32.75 | ★ $51.14 |
| AVG Volume (30 Days) | ★ 1.2M | 835.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.35 | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | ★ $2,730,200,000.00 | $787,309,000.00 |
| Revenue This Year | $3.51 | $6.77 |
| Revenue Next Year | $3.86 | $4.82 |
| P/E Ratio | ★ N/A | $1,018.38 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $19.50 | $22.66 |
| 52 Week High | $41.40 | $51.84 |
Technical Indicators
Market Signals| Indicator | QDEL | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 32.93 | 48.89 |
| Support Level | $19.50 | $29.19 |
| Resistance Level | $30.92 | $45.36 |
| Average True Range (ATR) | 1.69 | 1.47 |
| MACD | -0.12 | 0.53 |
| Stochastic Oscillator | 11.94 | 83.86 |
Price Performance
Historical ComparisonAbout QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.